$0.03
(Market cap
$-- Mln
Recently Viewed
Clear AllMarket cap
$-- Mln
Revenue (TTM)
$35 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-27 Mln
ROE
0 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
0
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
0
CFO
$-274.60 Mln
EBITDA
$-301.40 Mln
Net Profit
$-318.55 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Selecta Biosciences (SELB)
| 32.1 | 12.3 | 38.2 | 52.3 | -23.0 | -16.0 | -- |
|
BSE Sensex*
| -8.3 | 4.2 | -5.6 | -2.4 | 9.2 | 10.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Selecta Biosciences (SELB)
| 32.1 | -65.3 | 7.6 | 27.3 | -10.5 | -72.7 | -42.8 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Selecta Biosciences (SELB)
|
0.7 | -- | 34.5 | -40.3 | -169.5 | -59.7 | -- | 0.0 |
| 73.9 | 9,733.6 | 1,091.0 | 202.3 | 31.6 | 31.3 | 43.4 | 17.1 | |
| 66.3 | 8,216.2 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.3 | |
| 46.9 | 11,658.3 | 2,320.1 | 782.6 | 39.0 | 35.5 | 16.1 | 5.3 | |
| 89.6 | 11,852.6 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 68.4 | 8,209.1 | 1,396.6 | 316.9 | 59.8 | 153.6 | 27.1 | 161.7 | |
| 529.1 | 12,204.5 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 20.3 | |
| 508.5 | 14,867.3 | 2,530.2 | 451.1 | 21.3 | 70.2 | 34 | 32.4 | |
| 108.9 | 8,460.0 | 0.0 | -425.4 | -- | -36.7 | -- | 6.8 | |
| 337.3 | 9,538.9 | 0.0 | -303.3 | -- | -45.8 | -- | 10.9 |
--
CEO, Pres & Director
Dr. Carsten Brunn Ph.D.
VP of Fin. & Controller
Ms. Ann K. Donohue CPA
Headquarters
Watertown, MA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Selecta Biosciences Inc (SELB) is $0.75 (NASDAQ) as of 26-Dec-2023 09:30 EDT. Selecta Biosciences Inc (SELB) has given a return of -23% in the last 3 years.
Since, TTM earnings of Selecta Biosciences Inc (SELB) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
The 52-week high and low of Selecta Biosciences Inc (SELB) are Rs -- and Rs -- as of 23-Apr-2026.
Selecta Biosciences Inc (SELB) has a market capitalisation of -- as on 26-Dec-2023. As per SEBI classification, it is a Small Cap company.
Before investing in Selecta Biosciences Inc (SELB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.